Search
Bristol-Myers Squibb Co
BMYAdd to Watchlist
61.150USD
+0.320+0.53%
Close 10-02 16:00（ET）
124.87BMarket Cap
17.12P/E TTM
After-hours 19:00 (ET)61.150USD+0.010+0.02%
After-hours 19:00 (ET)Bristol-Myers Squibb Co (BMY) Stock Price Target & Forecast
Analyst Rating
Based on 31 analysts giving stock ratings to Bristol-Myers Squibb Co in the past month.
Buy
5 Strong Buy
6 Buy
18 Hold
2 Sell
0 Strong Sell
Target Price
66.808USD+8.70%
BMY Analyst Recommendation Trends
In the current month, BMY has received 6 Buy Ratings, 18 Hold Ratings, and 2 Sell Ratings. BMY average Analyst price target in the last month is 66.808.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
5
5
5
5
5
5
5
3
6
6
7
7
7
6
5
5
18
18
18
18
18
17
18
20
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
31
31
32
32
32
30
30
30
BMY Analyst Rating for Peer Comparison
Updated: Oct 2, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
12
18
2
1
37
Biogen Inc
BIIB
8
16
12
1
0
37
AbbVie Inc
ABBV
8
19
6
0
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
18
3
1
0
32
Merck & Co Inc
MRK
8
14
10
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Financial Forecasting
Based on analysts' estimates, BMY EPS is projected to reach 1.725 in FY2026Q3, following reported EPS of 1.624 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
1.12
1.42
1.59
1.72
1.59
Actual
0.53
1.31
1.62
--
--
Surprise
-52.09%
-7.30%
+2.29%
--
--
FAQs
What is Bristol-Myers Squibb Co's expected revenue for the next quarter?
Bristol-Myers Squibb Co's expected revenue is 12.58B.
What is Bristol-Myers Squibb Co's price target?
Analysts forecast that Bristol-Myers Squibb Co's price target is USD 66.81, with the highest forecast at USD 82.00 and the lowest forecast at USD 40.00.
How have Bristol-Myers Squibb CoBMY's recent earnings per share performed?
The market expectation was USD 1.62, while Bristol-Myers Squibb CoBMY's earnings per share (EPS) for the previous quarter was USD 1.31. EPS for the next quarter is expected at USD 1.72.
What is the analyst rating for Bristol-Myers Squibb Co?
Based on the ratings of Bristol-Myers Squibb Co's stock from 31 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.